Stay updated on DETERMINE-preserved: Dapagliflozin Clinical Trial
Sign up to get notified when there's something new on the DETERMINE-preserved: Dapagliflozin Clinical Trial page.

Latest updates to the DETERMINE-preserved: Dapagliflozin Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedPubMed publication note wording updated to indicate automatic filling from PubMed and the revision label upgraded to v3.3.2; the previous PubMed note and version v3.2.0 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check19 days agoChange DetectedRemoved the government funding status notice, which does not affect study content or data; the rest of the page content and location listings remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check41 days agoChange DetectedNo significant content changes were observed on the Study Details page; any differences are likely minor formatting or layout adjustments and do not affect the study information.SummaryDifference0.2%

- Check62 days agoChange DetectedUpdated operating-status notice and version 3.2.0; removed version 3.1.0.SummaryDifference3%

- Check70 days agoChange DetectedAdded revision label v3.1.0; removed several MedlinePlus topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and the older revision note v3.0.2.SummaryDifference0.4%

- Check84 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2. The Back to Top element was removed.SummaryDifference0.2%

Stay in the know with updates to DETERMINE-preserved: Dapagliflozin Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DETERMINE-preserved: Dapagliflozin Clinical Trial page.